{"id":"W2102672521","doi":"10.1158/1535-7163.mct-12-0753","title":"New Directions for Biologic Targets in Urothelial Carcinoma – Response","year":2012,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pazopanib; Sunitinib; Medicine; Cancer; Angiogenesis; Oncology; Kidney cancer; Bladder cancer; Renal cell carcinoma; Internal medicine; Cabozantinib; Disease; Urothelial cancer; Clinical trial; Metastatic Urothelial Carcinoma; Cancer research; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02044231,0.001082297,0.002638219,0.001513324,0.0009161365,0.004388035,0.002310706,0.00678727,0.01326335],"category_scores_gemma":[0.0136406,0.0004677782,0.002151331,0.00117759,0.003219563,0.01249666,0.002270357,0.01707137,0.005694384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00385496,"about_ca_system_score_gemma":0.003351136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006299273,"about_ca_topic_score_gemma":0.001739487,"domain_scores_codex":[0.9936165,0.00310599,0.0007086858,0.0006579104,0.001379908,0.0005309822],"domain_scores_gemma":[0.9809228,0.01076262,0.001767585,0.0010429,0.003514516,0.001989641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001813223,0.001078646,0.002406319,0.003560898,0.0003869864,0.0006520218,0.0002823118,0.0008693537,0.003652772,0.03267265,0.3750356,0.5775892],"study_design_scores_gemma":[0.0007992529,0.002059735,0.003738342,0.002378169,0.0003207693,0.001076727,0.0004631796,0.001970714,0.001011453,0.04189664,0.9441752,0.0001097567],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.002204539,0.3783679,0.005290569,0.5844929,0.02126061,0.0001609631,0.000264631,0.0003943774,0.007563448],"genre_scores_gemma":[0.04982557,0.3953149,0.01808509,0.3684272,0.1544698,0.0007984845,0.0008404652,0.0002894648,0.01194897],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.02044231,"threshold_uncertainty_score":0.1081105,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04273587198293374,"score_gpt":0.3319990055073346,"score_spread":0.2892631335244009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}